Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

CVS Group appoints David Wilton as its new chair

(Sharecast News) - UK veterinary service provider CVS announced the appointment of David Wilton as its new chair on Wednesday. The AIM-traded firm said Wilton, who had served as an independent non-executive director since September 2021, had over 30 years of experience in finance, corporate governance and strategic leadership.

A qualified Chartered Accountant, he had held various senior roles including chief financial officer, non-executive director, and board chair across public and private-equity backed companies.

It said his background included significant involvement in mid-cap merger and acquisition and corporate finance, notably with Rothschilds.

Prior to his appointment at CVS, Wilton held key positions such as chief financial officer of Sumo Group and group finance director of WYG.

He also served as non-executive director and chair of the audit committee at Sweett Group and Frontier Developments, respectively.

"I am delighted to take on the role of chair," said David Wilton.

"I know the business well and I look forward to supporting the executive management team even more closely as we continue to grow the business and deliver value for all of our stakeholders."

Currently, Wilton held the position of non-executive director and chair designate at Gateley Holdings.

CVS said Wilton's appointment followed a comprehensive search led by the nomination committee, supported by a recruitment firm which identified a pool of candidates.

The board said it would now begin a search for a new independent audit committee chair, adding that Wilton would continue to serve in that role until the process concluded, after which he would step down as a member of the audit committee.

"On behalf of the board and colleagues at CVS, I would like to congratulate David on his appointment as chair, and thank Deborah for her contribution during her position as Interim chair," commented chief executive officer Richard Fairman.

At 1306 BST, shares in CVS Group were down 1.78% at 961.59p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

Hummingbird announces restart at Kouroussa
(Sharecast News) - Hummingbird Resources announced the remobilization of Corica Mining Services at the Kouroussa Gold Mine in Guinea on Friday, after a work stoppage on March 17.
Drilling to start on Oracle's Northern Zone project
(Sharecast News) - Oracle Power announced on Friday that drilling is set to start next week at the Northern Zone Gold Project, 25 kilometres east of Kalgoorlie in Western Australia.
Fulcrum Metals extends date for sale of uranium assets
(Sharecast News) - Fulcrum Metals announced an extension to the completion date for the proposed sale of its Saskatchewan uranium projects to Terra Balcanica Resources on Friday.
PipeHawk subsidiary awarded £0.75m contract
(Sharecast News) - PipeHawk announced on Friday that an unnamed building materials company had awarded its subsidiary QM Systems a significant contract.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.